Product-specific bioequivalence guidance

EMEA-003587-PIP01-24

EMEA-003360-PIP01-22

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 20-22 January 2025

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Agenda - European medicines agencies network strategy (EMANS) to 2028 - webinar

Nilotinib product-specific bioequivalence guidance

Overview of comments received on `Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance’ (EMA/CHMP/518671/2023)

Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance

EMEA-000802-PIP01-09